Evercore ISI raised the firm’s price target on Teladoc (TDOC) to $6 from $5 and keeps an In Line rating on the shares. The firm made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TDOC:
- Pineal Capital urges Teladoc to cut more costs, consider break-up of core units
- Teladoc Adds Susan Salka to Expanded Board of Directors
- Private Markets: OpenAI raises additional $10B funding
- Teladoc price target lowered to $7 from $8.50 at Barclays
- Buy/Sell: Wall Street’s top 10 stock calls this week